Found: 18
Select item for more details and to access through your institution.
FDA Drug Approvals. Pipeline preview.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 400
- Publication type:
- Article
FDA Drug Approvals. . New molecular entities.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 400
- Publication type:
- Article
FDA Drug Approvals. FDA actions in brief.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 401
- Publication type:
- Article
Early antiretroviral therapy reduces HIV-1 transmission risk to uninfected partners in sexually active couples.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 402
- Publication type:
- Article
New study details increased international participation in US NHLBI-sponsored cardiovascular trials; further scrutiny warranted.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 402
- Publication type:
- Article
Pentavalent vaccine reduces rotavirus-associated healthcare use and cost in children less than 5 years of age.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 403
- Publication type:
- Article
Certain DMARDs associated with an increased incidence of diabetes in patients with psoriasis or RA.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 404
- Publication type:
- Article
Drug companies should report clinical trial results, even when they won't lead to a product.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 404
- Publication type:
- Article
Dapagliflozin: An emerging treatment option for type 2 diabetes mellitus.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 412
- By:
- Publication type:
- Article
Osteoporosis: A review of current recommendations and emerging treatment options.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 432
- By:
- Publication type:
- Article
Meeting Coverage. Collaborative helps pharmacists navigate EHR arena.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 447
- By:
- Publication type:
- Article
Meeting Coverage. More potent VEGF targeting improves PFS as second-line treatment in metastatic renal cell carcinoma.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 447
- Publication type:
- Article
Medication Safety and Reliability. Meta-analysis: anti-IL-12/23 agents have no effect on the cardiovascular risk of chronic plaque psoriasis patients.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 448
- Publication type:
- Article
Medication Safety and Reliability. Zoledronic acid (Reclast) prescribing information to list renal dysfunction as contraindication.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 448
- Publication type:
- Article
Medication Safety and Reliability. Labels for TNF-alpha blockers to warn of potential for infection.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 449
- Publication type:
- Article
Policy Watch. Global health challenges spur development of vaccines at home and abroad.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 450
- By:
- Publication type:
- Article
Drug Watch. Lung diseases (COPD and asthma).
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 452
- Publication type:
- Article
Drug Watch. Lung diseases (COPD and asthma)
- Published in:
- 2011
- Publication type:
- Journal Article